21例新型冠状病毒肺炎患者药物治疗方案的回顾性分析

Retrospective Analysis of 21 COVID-19 Patients’Therapeutic Regimen

目的对21例治愈出院的新型冠状病毒肺炎患者的治疗方案进行评价分析,为后续病例的诊治提供参考。方法回顾性分析2020年2—4月治愈出院的新型冠状病毒肺炎患者的病例资料及药物治疗方案。结果所有确诊患者均有流行病学史,以普通型(90.5%)为主,依据诊疗方案给予抗病毒治疗和其他支持治疗,疗效和安全性良好,所有患者均治愈出院。结论临床药师应追踪新型冠状病毒肺炎研究进展,参与方案制定,针对患者个体化情况,提出药学建议,保证患者的安全合理用药。

OBJECTIVE To evaluate the medical treatment of 21 COVID-19 discharged patients,and provide reference for the diagnosis and treatment of follow-up cases.METHODS Retrospectively analyzed the case data and medical treatment of COVID-19 patients who were discharged from February 2020 to April 2020.RESULTS All the patients had an epidemiological history,the mainly type was common(90.5%).Antiviral treatment and other supportive treatment were given,with good efficacy and safety.All patients were cured and discharged.CONCLUSION Clinical pharmacists should actively participate in the formulation of therapeutic regimen for COVID-19.The pharmaceutical suggestions are put forward to ensure the rational use of drugs and safety.